ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain
Clinical trial NCT07568015 · RECRUITING
Trial details
- NCT number
- NCT07568015
- Sponsor
- Brixton Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-27
- Primary completion
- 2027-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.